- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 92.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 94.23M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 64.03M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $75.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $21.63M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $14.27M |
| Capex | Q1 2026 · Mar 31, 2026 | $6.33M |
| Capex | Q1 2026 · Mar 31, 2025 | $4.82M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $100.06M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $50.1M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $500.34M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $499.76M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $305.86M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $555.77M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.22B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.07B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.87B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.88B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.73B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.68B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $23.24B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $22.87B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $27.11B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $26.75B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $18.27B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.94 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.65 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.94 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.65 |
| Net Income | Q1 2026 · Mar 31, 2026 | $88.23M |
| Net Income | Q1 2026 · Mar 31, 2025 | $41.52M |